Status:

COMPLETED

BELotaxel(Docetaxel) and bellOXa(Oxaliplatin) in Advanced NSCLC

Lead Sponsor:

Chonnam National University Hospital

Collaborating Sponsors:

Chong Kun Dang Pharmaceutical

Conditions:

Non-Small Cell Lung Cancer

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

Lung cancer is the leading cause of cancer death in Korea as well as in other countries. About 80% of lung cancer is non-small cell lung cancer(NSCLC). The majority of patients with NSCLC require cyto...

Eligibility Criteria

Inclusion

  • Stage IIIB/IV or Relapsed NSCLC
  • Age \>= 18 years
  • At least one measurable lesion by RECIST (version 1.1)
  • ECOG PS 0, 1, 2
  • Hematologic profile
  • Hgb \> 8 g/dL, ANC \>= 2,000/m3, Platelet \>= 100,000/m3
  • Hepatic profile
  • Total bilirubin \<= 1.5 x upper normal value
  • Transaminases \<= 3 x upper normal value \<= 5 x upper normal value in case of liver metastasis
  • Creatinine \<= 1.5mg/dL
  • Patients should be recovered from toxicities of previous treatment.
  • Written informed consent by patient or surrogates

Exclusion

  • Patients who had been previously treated with chemotherapy for NSCLC
  • Active infection requiring antibiotics treatment
  • Prior diagnosis of other malignancy except radically treated basal cell or squamous cell carcinoma of the skin and carcinoma in situ of the uterine cervix
  • Peripheral neuropathy \>= grade 2 by NCI CTCAE 4.0
  • Uncontrolled hypertension, Acute myocardial infarction within 6 months Unstable angina, Congestive heart failure \>= NYHA grade 2 Uncontrolled significant arrhythmia
  • Patients who entered other clinical trials within 4 weeks
  • Pregnant or lactating women. women with child bearing age who are not willing to a contraceptive measure

Key Trial Info

Start Date :

November 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 1 2013

Estimated Enrollment :

33 Patients enrolled

Trial Details

Trial ID

NCT01243775

Start Date

November 1 2010

End Date

January 1 2013

Last Update

August 17 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Chonnam National University Hwasun Hospital

Hwasun, Jeollanam-do, South Korea, 519-809

BELotaxel(Docetaxel) and bellOXa(Oxaliplatin) in Advanced NSCLC | DecenTrialz